Further definition by cytotoxicity tests of cell surface antigens of human sarcomas in culture.
D000941:Antigens / Q000032:analysis*; D000951:Antigens, Neoplasm / Q000032:analysis; D001943:Breast Neoplasms / Q000276:immunology; D002294:Carcinoma, Squamous Cell / Q000276:immunology; D002460:Cell Line / Q000276:immunology; D002478:Cells, Cultured; D002813:Chondrosarcoma / Q000276:immunology; D003110:Colonic Neoplasms / Q000276:immunology; D003165:Complement System Proteins; D003601:Cytotoxicity Tests, Immunologic; D004407:Dysgerminoma / Q000276:immunology; D005260:Female; D005347:Fibroblasts / Q000276:immunology; D006801:Humans; D007111:Immunity, Cellular; D066298:In Vitro Techniques; D008545:Melanoma / Q000276:immunology; D008654:Mesothelioma / Q000276:immunology; D009447:Neuroblastoma / Q000276:immunology; D012516:Osteosarcoma / Q000276:immunology; D012208:Rhabdomyosarcoma / Q000276:immunology; D012509:Sarcoma / Q000276:immunology*; D012512:Sarcoma, Ewing / Q000276:immunology; D002583:Uterine Cervical Neoplasms / Q000276:immunology
D000941:Antigens; D000951:Antigens, Neoplasm; D003165:Complement System Proteins